Florian Willecke

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 01, 2019
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.

Jan Pennig, Philipp Scherrer, Mark Colin Gissler

Pageof 1

Frequent Collaborators

1 joint publications

Dennis Wolf